Advanced search
Publication Cover
Epigenetics Volume 8, 2013 - Issue 1
Submit an article Journal homepage
1,359
Views
71
CrossRef citations to date
0
Altmetric
Research Paper

Aberrant Keap1 methylation in breast cancer and association with clinicopathological features

Raffaela Barbano Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Lucia Anna Muscarella Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Barbara Pasculli Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy; Department of Biosciences, Biotecnology and Pharmacological Sciences; University Of Bari; Bari, Italy
,
Vanna Maria Valori Department of Oncohaematology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Andrea Fontana Unit of Biostatistics; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Michelina Coco Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Annamaria la Torre Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Teresa Balsamo Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Maria Luana Poeta Department of Biosciences, Biotecnology and Pharmacological Sciences; University Of Bari; Bari, Italy
,
Giovanni Francesco Marangi Plastic and Reconstructive Surgery Department; University Campus BioMedico; Rome, Italy
,
Evaristo Maiello Department of Oncohaematology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Marina Castelvetere Department of Pathology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Fabio Pellegrini Unit of Biostatistics; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy; Unit of Biostatistics; Department of Clinical Pharmacology and Epidemiology; Consorzio Mario Negri Sud; S. Maria Imbaro, Italy
,
Roberto Murgo Breast Unit; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy
,
Vito Michele Fazio Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, Italy; Molecular Medicine and Biotechnology Laboratory; University Campus BioMedico; Rome, ItalyCorrespondence[email protected] [email protected]
&
Paola Parrella Laboratory of Oncology; IRCCS “Casa Sollievo della Sofferenza”; San Giovanni Rotondo, ItalyCorrespondence[email protected] [email protected]
 show all
Pages 105-112 | Received 19 Oct 2012, Accepted 17 Dec 2012, Published online: 18 Dec 2012

Citations (71)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Amit Sharma, Hongde Liu, Martina C. Herwig-Carl, Tikam Chand Dakal & Ingo G H Schmidt-Wolf. (2021) Epigenetic Regulatory Enzymes: mutation Prevalence and Coexistence in Cancers. Cancer Investigation 39:3, pages 257-273.
Read now
Michael J. Kerins, Pengfei Liu, Wang Tian, William Mannheim, Donna D. Zhang & Aikseng Ooi. (2019) Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2 Transcription Factor. Molecular and Cellular Biology 39:13.
Read now
Bo Zhang, Zhiyuan Ma, Biqin Tan & Nengming Lin. (2019) Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung. Expert Opinion on Therapeutic Targets 23:3, pages 241-250.
Read now
Francesca Tavano, Valerio Pazienza, Andrea Fontana, Francesca Paola Burbaci, Concita Panebianco, Chiara Saracino, Lucia Lombardi, Antonio De Bonis, Fabio Francesco di Mola, Pierluigi di Sebastiano, Ada Piepoli, Manlio Vinciguerra, Massimo Fracavilla, Francesco Giuliani, Rosa Rubino, Angelo Andriulli & Gianluigi Mazzoccoli. (2015) SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation. Chronobiology International 32:4, pages 497-512.
Read now
Claudia Geismann, Alexander Arlt, Susanne Sebens & Heiner Schäfer. (2014) Cytoprotection “gone astray”: Nrf2 and its role in cancer. OncoTargets and Therapy 7, pages 1497-1518.
Read now

Articles from other publishers (66)

Xiaoting Zhou, Biao An, Yi Lin, Yanghong Ni, Xia Zhao & Xiao Liang. (2023) Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies. Biomedicine & Pharmacotherapy 165, pages 115036.
Crossref
Karla Rubio, Estefani Y. Hernández-Cruz, Diana G. Rogel-Ayala, Pouya Sarvari, Ciro Isidoro, Guillermo Barreto & José Pedraza-Chaverri. (2023) Nutriepigenomics in Environmental-Associated Oxidative Stress. Antioxidants 12:3, pages 771.
Crossref
Negin Soghli, Hassan Yousefi, Tohid Naderi, Aysan Fallah, Amin Moshksar, Farzaneh Darbeheshti, Cecilia Vittori, Mahsa Rostamian Delavar, Ali Zare, Habib Sadeghi Rad, Abtin Kazemi, Amirreza Bitaraf, Bashdar Mahmud Hussen, Mohammad Taheri & Elena Jamali. (2023) NRF2 signaling pathway: A comprehensive prognostic and gene expression profile analysis in breast cancer. Pathology - Research and Practice 243, pages 154341.
Crossref
Young Sub Lee, Jun Kang, Eun Sun Jung & Ahwon Lee. (2023) High Expression of NRF2 and Low Expression of KEAP1 Predict Worse Survival in Patients With Operable Triple-Negative Breast Cancer. Journal of Breast Cancer 26:5, pages 461.
Crossref
·买合木提 祖丽皮耶. (2023) Advances in the Role of Nrf2 in the Development of Breast Cancer and the Development of Drug Resistance. Advances in Clinical Medicine 13:10, pages 16361-16367.
Crossref
Farhad Pouremamali, Amir Pouremamali, Mehdi Dadashpour, Narges Soozangar & Farhad Jeddi. (2022) An update of Nrf2 activators and inhibitors in cancer prevention/promotion. Cell Communication and Signaling 20:1.
Crossref
Mustafa Yildiz & Hatice Segmen. 2022. Molecular Mechanisms in Cancer. Molecular Mechanisms in Cancer.
Shunhao Zhang, Sining Duan, Zhuojun Xie, Wanlin Bao, Bo Xu, Wenbin Yang & Lingyun Zhou. (2022) Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress. Frontiers in Pharmacology 13.
Crossref
Ray Pillai, Makiko Hayashi, Anastasia-Maria Zavitsanou & Thales Papagiannakopoulos. (2022) NRF2: KEAPing Tumors Protected. Cancer Discovery 12:3, pages 625-643.
Crossref
Ashita Gadwal, Anupama Modi, Manoj Khokhar, Jeewan Ram Vishnoi, Ramkaran Choudhary, Poonam Elhence, Mithu Banerjee & Purvi Purohit. (2021) Critical appraisal of epigenetic regulation of galectins in cancer. International Journal of Clinical Oncology 27:1, pages 35-44.
Crossref
Mariam Ashfaq Khan. 2022. Breast Cancer: From Bench to Personalized Medicine. Breast Cancer: From Bench to Personalized Medicine 145 183 .
Shamee Bhattacharjee. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 1437 1455 .
Shamee Bhattacharjee. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects 1 19 .
Thilona Arumugam, Terisha Ghazi & Anil A. Chuturgoon. (2021) Fumonisin B1 alters global m6A RNA methylation and epigenetically regulates Keap1-Nrf2 signaling in human hepatoma (HepG2) cells. Archives of Toxicology 95:4, pages 1367-1378.
Crossref
Katarína SmolkováEdit MikóTünde KovácsAlberto Leguina-RuzziAdrienn SiposPéter Bai. (2020) Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism. Antioxidants & Redox Signaling 33:13, pages 966-997.
Crossref
Jae Hyung Park, Woo Yang Pyun & Hyun Woo Park. (2020) Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets. Cells 9:10, pages 2308.
Crossref
Federico Pio Fabrizio, Tommaso Mazza, Stefano Castellana, Angelo Sparaneo & Lucia Anna Muscarella. (2020) Epigenetic Scanning of KEAP1 CpG Sites Uncovers New Molecular-Driven Patterns in Lung Adeno and Squamous Cell Carcinomas. Antioxidants 9:9, pages 904.
Crossref
Shamee Bhattacharjee & Roderick H. Dashwood. (2020) Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals. Antioxidants 9:9, pages 865.
Crossref
Essam Eldin Mohamed Nour Eldin, Mohamed Mahmoud Nour Eldein, Mahmoud Zaki El-Readi, Ahmad A. Mirza, Sameer Hasan Fatani, Hiba Saeed Al-Amodi, Mohammad Ahmad Althubiti, Esmail M.  Al-Ezzi, Safaa Yehia Eid & Hala Fawzy Mohammed Kamel. (2020) Evaluation of the Diagnostic and Predicative Values of 8-Iso-Prostaglandin F2α as a Biomarker of Breast Cancer. Oncology Research and Treatment 43:10, pages 506-517.
Crossref
Xiaoxian Shi, Senfeng Xiang, Ji Cao, Hong Zhu, Bo Yang, Qiaojun He & Meidan Ying. (2019) Kelch-like proteins: Physiological functions and relationships with diseases. Pharmacological Research 148, pages 104404.
Crossref
Linbo Gao, Fang Yuan, Guanglu Che, Xiao Xiao, Xinwen Nie, Yanyun Wang, Jin Jia, Ah‐Ng Kong & Lin Zhang. (2019) Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer . Journal of Cellular Biochemistry 120:8, pages 12311-12320.
Crossref
Federico Fabrizio, Angelo Sparaneo, Flavia Centra, Domenico Trombetta, Clelia Storlazzi, Paolo Graziano, Evaristo Maiello, Vito Fazio & Lucia Muscarella. (2019) Methylation Density Pattern of KEAP1 Gene in Lung Cancer Cell Lines Detected by Quantitative Methylation Specific PCR and Pyrosequencing. International Journal of Molecular Sciences 20:11, pages 2697.
Crossref
Emiliano Panieri & Luciano Saso. (2019) Potential Applications of NRF2 Inhibitors in Cancer Therapy. Oxidative Medicine and Cellular Longevity 2019, pages 1-34.
Crossref
Esa Kari, Hanna-Riikka Teppo, Kirsi-Maria Haapasaari, Milla Elvi Linnea Kuusisto, Aurora Lemma, Peeter Karihtala, Risto Pirinen, Ylermi Soini, Esa Jantunen, Taina Turpeenniemi-Hujanen & Outi Kuittinen. (2019) Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP. Journal of Clinical Pathology 72:4, pages 316-321.
Crossref
Xuerong Zhou, Ling Zhao, Jie Luo, Huaqiao Tang, Min Xu, Yanyan Wang, Xiaoyu Yang, Helin Chen, Yinglun Li, Gang Ye, Fei Shi, Cheng Lv & Bo Jing. (2019) The Toxic Effects and Mechanisms of Nano-Cu on the Spleen of Rats. International Journal of Molecular Sciences 20:6, pages 1469.
Crossref
Haipeng Huang, Yunhong Wu, Weijin Fu, Xiaoming Wang, Liquan Zhou, Xiaolong Xu, Fu Huang & Yi Wu. (2019) Downregulation of Keap1 contributes to poor prognosis and Axitinib resistance of renal cell carcinoma via upregulation of Nrf2 expression. International Journal of Molecular Medicine.
Crossref
Narges Soozangar, Mohammad R. Sadeghi, Farhad Jeddi, Nasser Samadi, Mohammad S. Hejazi, Mehdi Azad, Masoud Shirmohamadi & Mohammad H. Somi. (2019) Decreased expression of the Keap1 gene and its clinicopathological significance in gastric cancer: correlation with promoter DNA methylation. Gazzetta Medica Italiana Archivio per le Scienze Mediche 178:5.
Crossref
Mahsa Darbandi, Sara Darbandi, Ashok Agarwal, Saradha Baskaran, Pallav Sengupta, Sulagna Dutta, Pooneh Mokarram, Kioomars Saliminejad & Mohammad Reza Sadeghi. (2019) Oxidative stress-induced alterations in seminal plasma antioxidants: Is there any association with keap1 gene methylation in human spermatozoa? . Andrologia 51:1, pages e13159.
Crossref
Beili Zhang, Jugang Wu, Yantao Cai, Meng Luo, Bing Wang & Yan Gu. (2019) TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer. Acta Biochimica et Biophysica Sinica 51:4, pages 375-385.
Crossref
Jong Woo Park & Jeung-Whan Han. (2019) Targeting epigenetics for cancer therapy. Archives of Pharmacal Research 42:2, pages 159-170.
Crossref
Matthew DodsonMontserrat Rojo de la VegaAram B. CholaniansCody J. SchmidlinEli ChapmanDonna D. Zhang. (2019) Modulating NRF2 in Disease: Timing Is Everything. Annual Review of Pharmacology and Toxicology 59:1, pages 555-575.
Crossref
Elina Urpilainen, Jenni Kangaskokko, Ulla Puistola & Peeter Karihtala. (2019) Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes. Tumor Biology 41:1, pages 101042831881541.
Crossref
Paola Parrella. (2018) The value of epigenetic biomarkers in breast cancer. Biomarkers in Medicine 12:9, pages 937-940.
Crossref
Barbara Pasculli, Raffaela Barbano & Paola Parrella. (2018) Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine. Seminars in Cancer Biology 51, pages 22-35.
Crossref
Jingze Zhang, Qinghua Jiao, Li Kong, Jing Yu, Aiju Fang, Minghuan Li & Jinming Yu. (2018) Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy. Thoracic Cancer 9:6, pages 726-735.
Crossref
Daniela Senft, Jianfei Qi & Ze'ev A. Ronai. (2017) Ubiquitin ligases in oncogenic transformation and cancer therapy. Nature Reviews Cancer 18:2, pages 69-88.
Crossref
F. P. Fabrizio, A. Sparaneo, D. Trombetta & L. A. Muscarella. (2018) Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs. Oxidative Medicine and Cellular Longevity 2018, pages 1-21.
Crossref
Heena Singla, Abhilash Ludhiadch, Raman Preet Kaur, Harish Chander, Vinod Kumar & Anjana Munshi. (2017) Recent advances in HER2 positive breast cancer epigenetics: Susceptibility and therapeutic strategies. European Journal of Medicinal Chemistry 142, pages 316-327.
Crossref
Violetta Krajka-Kuźniak, Jarosław Paluszczak & Wanda Baer-Dubowska. (2017) The Nrf2-ARE signaling pathway: An update on its regulation and possible role in cancer prevention and treatment. Pharmacological Reports 69:3, pages 393-402.
Crossref
Farhad Jeddi, Narges Soozangar, Mohammad Reza Sadeghi, Mohammad Hossein Somi & Nasser Samadi. (2017) Contradictory roles of Nrf2/Keap1 signaling pathway in cancer prevention/promotion and chemoresistance. DNA Repair 54, pages 13-21.
Crossref
Federico Pio Fabrizio, Manuela Costantini, Massimiliano Copetti, Annamaria la Torre, Angelo Sparaneo, Andrea Fontana, Luana Poeta, Michele Gallucci, Steno Sentinelli, Paolo Graziano, Paola Parente, Vincenzo Pompeo, Laura De Salvo, Giuseppe Simone, Rocco Papalia, Francesco Picardo, Teresa Balsamo, Gerardo Paolo Flammia, Domenico Trombetta, Angela Pantalone, Klaas Kok, Ferronika Paranita, Lucia Anna Muscarella & Vito Michele Fazio. (2017) Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma. Oncotarget 8:7, pages 11187-11198.
Crossref
Nelli Roininen, Kirsi-Maria Haapasaari & Peeter Karihtala. (2017) The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy. Oxidative Medicine and Cellular Longevity 2017, pages 1-9.
Crossref
Priyanka Basak, Pritam Sadhukhan, Poulami Sarkar & Parames C. Sil. (2017) Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy. Toxicology Reports 4, pages 306-318.
Crossref
David Cheng, Renyi Wu, Yue Guo & Ah-Ng Tony Kong. (2016) Regulation of Keap1–Nrf2 signaling: The role of epigenetics. Current Opinion in Toxicology 1, pages 134-138.
Crossref
Brandon John Praslicka, Michael John Kerins & Aikseng Ooi. (2016) The complex role of NRF2 in cancer: A genomic view. Current Opinion in Toxicology 1, pages 37-45.
Crossref
Carolina Panis, Bruno Pires, Ana de Andrade, Mateus Silva & Vanessa Victorino. 2016. Reactive Oxygen Species in Biology and Human Health. Reactive Oxygen Species in Biology and Human Health 243 257 .
Ching-Yu Yen, Hurng-Wern Huang, Chih-Wen Shu, Ming-Feng Hou, Shyng-Shiou F. Yuan, Hui-Ru Wang, Yung-Ting Chang, Ammad Ahmad Farooqi, Jen-Yang Tang & Hsueh-Wei Chang. (2016) DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Letters 373:2, pages 185-192.
Crossref
Jihong Zhang, Xiaojuan Wang, Wuzhou Wu, Hongsheng Dang & Bo Wang. (2016) Expression of the Nrf2 and Keap1 proteins and their clinical significance in osteosarcoma. Biochemical and Biophysical Research Communications 473:1, pages 42-46.
Crossref
Wafa Abu‐Alainin, Thompson Gana, Triantafillos Liloglou, Adedamola Olayanju, Lawrence N Barrera, Robert Ferguson, Fiona Campbell, Timothy Andrews, Christopher Goldring, Neil Kitteringham, Brian K Park, Taoufik Nedjadi, Michael C Schmid, Joseph R Slupsky, William Greenhalf, John P Neoptolemos & Eithne Costello. (2015) UHRF1 regulation of the Keap1–Nrf2 pathway in pancreatic cancer contributes to oncogenesis . The Journal of Pathology 238:3, pages 423-433.
Crossref
Joel Isohookana, Kirsi-Maria Haapasaari, Ylermi Soini & Peeter Karihtala. (2015) Keap1 expression has independent prognostic value in pancreatic adenocarcinomas. Diagnostic Pathology 10:1.
Crossref
Yue Guo, Siwang Yu, Chengyue Zhang & Ah-Ng Tony Kong. (2015) Epigenetic regulation of Keap1-Nrf2 signaling. Free Radical Biology and Medicine 88, pages 337-349.
Crossref
Ruud H. Wijdeven, Baoxu Pang, Sabina Y. van der Zanden, Xiaohang Qiao, Vincent Blomen, Marlous Hoogstraat, Esther H. Lips, Lennert Janssen, Lodewyk Wessels, Thijn R. Brummelkamp & Jacques Neefjes. (2015) Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer. Cancer Research 75:19, pages 4176-4187.
Crossref
Jun-Qi Ma, Hatila Tuersun, Shu-Juan Jiao, Jian-He Zheng, Jing-Bao xiao & Ayshamgul Hasim. (2015) Functional Role of NRF2 in Cervical Carcinogenesis. PLOS ONE 10:8, pages e0133876.
Crossref
Naomi Dicks, Karina Gutierrez, Marek Michalak, Vilceu Bordignon & Luis B. Agellon. (2015) Endoplasmic Reticulum Stress, Genome Damage, and Cancer. Frontiers in Oncology 5.
Crossref
Velio Bocci & Giuseppe Valacchi. (2015) Nrf2 activation as target to implement therapeutic treatments. Frontiers in Chemistry 3.
Crossref
Keiko Taguchi & Masayuki Yamamoto. 2015. Protein Modifications in Pathogenic Dysregulation of Signaling. Protein Modifications in Pathogenic Dysregulation of Signaling 269 285 .
Francesca Tavano, Andrea Fontana, Fabio Pellegrini, Francesca Paola Burbaci, Francesca Rappa, Francesco Cappello, Massimiliano Copetti, Evaristo Maiello, Lucia Lombardi, Paolo Graziano, Manlio Vinciguerra, Fabio Francesco di Mola, Pierluigi di Sebastiano, Angelo Andriulli & Valerio Pazienza. (2014) Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients. Journal of Translational Medicine 12:1.
Crossref
Monique G.P. van der Wijst, Robert Brown & Marianne G. Rots. (2014) Nrf2, the master redox switch: The Achilles' heel of ovarian cancer?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1846:2, pages 494-509.
Crossref
Akhileshwar Namani, Yulong Li, Xiu Jun Wang & Xiuwen Tang. (2014) Modulation of NRF2 signaling pathway by nuclear receptors: Implications for cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:9, pages 1875-1885.
Crossref
Periyasamy Palsamy, Keshore R. Bidasee, Masahiko Ayaki, Robert C. Augusteyn, Jefferson Y. Chan & Toshimichi Shinohara. (2014) Methylglyoxal induces endoplasmic reticulum stress and DNA demethylation in the Keap1 promoter of human lens epithelial cells and age-related cataracts. Free Radical Biology and Medicine 72, pages 134-148.
Crossref
Jae Hong No, Yong-Beom Kim & Yong Sang Song. (2014) Targeting Nrf2 Signaling to Combat Chemoresistance. Journal of Cancer Prevention 19:2, pages 111-117.
Crossref
M Hussong, S T Börno, M Kerick, A Wunderlich, A Franz, H Sültmann, B Timmermann, H Lehrach, M Hirsch-Kauffmann & M R Schweiger. (2014) The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response. Cell Death & Disease 5:4, pages e1195-e1195.
Crossref
John D. Hayes & Albena T. Dinkova-Kostova. (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends in Biochemical Sciences 39:4, pages 199-218.
Crossref
Hanna M. Leinonen, Emilia Kansanen, Petri Pölönen, Merja Heinäniemi & Anna-Liisa Levonen. 2014. Redox and Cancer Part A. Redox and Cancer Part A 281 320 .
Gayathri R. Devi, Jennifer L. Allensworth, Myron K. Evans & Scott J. Sauer. 2014. Cancer. Cancer 3 14 .
Chiara Gorrini, Pegah S. Baniasadi, Isaac S. Harris, Jennifer Silvester, Satoshi Inoue, Bryan Snow, Purna A. Joshi, Andrew Wakeham, Sam D. Molyneux, Bernard Martin, Peter Bouwman, David W. Cescon, Andrew J. Elia, Zoe Winterton-Perks, Jennifer Cruickshank, Dirk Brenner, Alan Tseng, Melinda Musgrave, Hal K. Berman, Rama Khokha, Jos Jonkers, Tak W. Mak & Mona L. Gauthier. (2013) BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival. Journal of Experimental Medicine 210:8, pages 1529-1544.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.